iOMEDICO AG
Freiburg, Baden-Wuerttemberg, Germany
Research institute in Freiburg im Breisgau, Baden-Württemberg
Ellen-Gottlieb-Straße 19, 79106 Freiburg im Breisgau
About iOMEDICO AG
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
iOMEDICO AG
8
University Hospital, Essen
1
Clinical Trials at iOMEDICO AG
During the past decade, iOMEDICO AG conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab
2014-08-01
2017-09-30
Completed
85
Trial of BKM120/Tamoxifen-combination in Patients With HR-pos, HER2-neg Breast Cancer
2014-12-01
2017-10-19
Completed
48
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "iOMEDICO AG"
#1 collaborator was "Arbeitsgemeinschaft fur Internistische Onkologie" with 3 trials as a collaborator, "Arbeitskreis Klinische Studien" with 2 trials as a collaborator, "Novartis Pharmaceuticals" with 2 trials as a collaborator, "ASORS" with 1 trials as a collaborator and "ASORS (Arbeitsgemeinschaft Supportive Maßnahmen in der Onkologie, Rehabilitation und Sozialmedizin der Deutschen Krebsgesellschaft)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at iOMEDICO AG
According to Clinical.Site data, the most researched conditions in "iOMEDICO AG" are
"AML" (1 trials), "Advanced Breast Cancer" (1 trials), "Anemia" (1 trials), "Antiemetic Therapy" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "iOMEDICO AG" in a lesser frequency.
Clinical Trials Intervention Types at iOMEDICO AG
Most popular intervention types in "iOMEDICO AG" are "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "BKM120" (1 trials), "Bevacizumab" (1 trials), "Capecitabine" (1 trials), "Docetaxel" (1 trials) and "Everolimus" (1 trials). Other intervention names were less common.
Clinical Trials Genders at iOMEDICO AG
The vast majority of trials in "iOMEDICO AG" are
5 trials for "All" genders and 4 trials for "Female" genders.
Clinical Trials Status at iOMEDICO AG
Currently, there are NaN active trials in "iOMEDICO AG".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in iOMEDICO AG,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in iOMEDICO AG, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".